Related scientific articles (all)

Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study.

Authors : Pérez-García JM, Gebhart G, Borrego MR, Schmid P, Marmé F, Prat A, Dalenc F, Kerrou K, Colleoni M, Braga S, Malfettone A, Sampayo-Cordero M, Cortés J, Llombart-Cussac A
Year : 2022
Journal : Future Oncol
Volume : 18
Pages : 3677-3688

Polypoid colon mucosa in a leukemia patient.

Authors : Lifrange F, Van Gossum A, Verset L, Bron D, Gomez-Galdon M, Demetter P
Year : 2022
Journal : Acta Gastroenterol Belg
Volume : 85
Pages : 118-119

Understanding the Radiobiological Mechanisms Induced by (177)Lu-DOTATATE in Comparison to External Beam Radiation Therapy.

Authors : Delbart W, Karabet J, Marin G, Penninckx S, Derrien J, Ghanem GE, Flamen P, Wimana Z
Year : 2022
Journal : Int J Mol Sci
Volume : 23

Mind the target: human epidermal growth factor receptor 2 in colorectal cancer.

Authors : Saude Conde R, Rasschaert G, Bregni G, Hendlisz A, Sclafani F
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 382-388

Delivering precision oncology to patients with cancer.

Authors : Mateo J, Steuten L, Aftimos P, André F, Davies M, Garralda E, Geissler J, Husereau D, Martinez-Lopez I, Normanno N, Reis-Filho JS, Stefani S, Thomas DM, Westphalen CB, Voest E
Year : 2022
Journal : Nat Med
Volume : 28
Pages : 658-665

Development of fluorizoline analogues as prohibitin ligands that modulate C-RAF signaling, p21 expression and melanogenesis.

Authors : Chouha N, Abou-Hamdan H, Yurugi H, Yoshii R, Ii H, Najem A, Ghanem GE, Nakata S, Rajalingam K, Peng Y, Wang D, Nebigil CG, Désaubry L
Year : 2022
Journal : Eur J Med Chem
Volume : 242
Pages : 114635

First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study.

Authors : Lenz HJ, van Cutsem E, Luisa Limon M, Wong KYM, Hendlisz A, Aglietta M, García-Alfonso P, Neyns B, Luppi G, Cardin DB, Dragovich T, Shah U, Abdullaev S, Gricar J, Ledeine JM, Overman MJ, Lonardi S
Year : 2022
Journal : J Clin Oncol
Volume : 40
Pages : 161-170

Non-invasive scoring of cellular atypia in keratinocyte cancers in 3D LC-OCT images using Deep Learning.

Authors : Fischman S, Pérez-Anker J, Tognetti L, Di Naro A, Suppa M, Cinotti E, Viel T, Monnier J, Rubegni P, Del Marmol V, Malvehy J, Puig S, Dubois A, Perrot JL
Year : 2022
Journal : Sci Rep
Volume : 12
Pages : 481

Regional Anesthesia For Breast Reconstruction

Authors : Ben Aziz M, Mukhdomi T
Year : 2022
Journal : StatPearls - Internet

Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis.

Authors : Carey LA, Loirat D, Punie K, Bardia A, Diéras V, Dalenc F, Diamond JR, Fontaine C, Wang G, Rugo HS, Hurvitz SA, Kalinsky K, OShaughnessy J, Loibl S, Gianni L, Piccart M, Zhu Y, Delaney R, Phan S, Cortés J
Year : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pages : 72

Editorial: Nutrition and the gastrointestinal tract.

Authors : Correia MITD, Van Gossum A
Year : 2022
Journal : Curr Opin Clin Nutr Metab Care
Volume : 25
Pages : 319-320

Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform.

Authors : Morfouace M, Novello S, Stevovic A, Dooms C, Berghmans T, Dziadziuszko R, Gorlia T, Felip E, Paz-Ares L, Mazieres J, OBrien M, Bironzo P, Vansteenkiste J, Lacroix L, Dingemans AC, Golfinopoulos V, Besse B
Year : 2022
Journal : Sci Rep
Volume : 12
Pages : 8342

HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study.

Authors : Gilles C, Rozenberg S, Buxant F, Manigart Y, de Wind R, Houte KV, Vandenbroeck D, Delforge M, Konopnicki D
Year : 2022
Journal : Vaccine
Volume : 40
Pages : 7230-7237

(68)Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy.

Authors : Shagera QA, Artigas C, Karfis I, Critchi G, Chanza NM, Sideris S, Peltier A, Paesmans M, Gil T, Flamen P
Year : 2022
Journal : J Nucl Med
Volume : 63
Pages : 1191-1198

Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY

Authors : Gelber Rd, Wang XV, Cole BF, Cameron D, Cardoso F, Tjan-Heijnen V, Krop I, Loi S, Salgado R, Kiermaier A, Frank E, Fumagalli D, Caballero C, de Azambuja E, Procter M, Clark E, Restuccia E, Heeson S, Bines J, Loibl S, Piccart-Gebhart M
Year : 2022
Journal : Eur J Cancer
Volume : 166
Pages : 219-228

Development of a Method for Producing oxLDL: Characterization of Their Effects on HPV-Positive Head and Neck Cancer Cells.

Authors : Scalia A, Kindt N, Trelcat A, Nachtergael A, Duez P, Journé F, Carlier S
Year : 2022
Journal : Int J Mol Sci
Volume : 23

Psychological interventions targeting patients with metastatic cancer and prolonged survival expectancies: advances and challenges.

Authors : Righes S, Lewis F, Waroquier P, Delevallez F, Merckaert I
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 256-264

Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma.

Authors : Najem A, Soumoy L, Sabbah M, Krayem M, Awada A, Journe F, Ghanem GE
Year : 2022
Journal : Cells
Volume : 11

OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.

Authors : Otmani K, Rouas R, Lewalle P
Year : 2022
Journal : Front Immunol
Volume : 13
Pages : 913951

Quality of pathology reporting and adherence to guidelines in rectal neuroendocrine neoplasms: a Belgian national study.

Authors : Waked B, De Maeyer F, Carton S, Pieter-Jan C, Vandamme T, Verslype C, Demetter P, Borbath I, Van Eycken L, Hoorens A, Geboes K, Van Damme N, Ribeiro S
Year : 2022
Journal : Acta Clin Belg
Volume : 77
Pages : 823-831